Eisai Co (TSE:4523) EPS (Diluted) : 円168.38 (TTM As of Dec. 2023)

View and export this data going back to 1961. Start your Free Trial

What is Eisai Co EPS (Diluted)?

Eisai Co's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was 円20.81. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円168.38.

Eisai Co's EPS (Basic) for the three months ended in Dec. 2023 was 円20.81. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was 円168.38.

Eisai Co's EPS without NRI for the three months ended in Dec. 2023 was 円20.81. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was 円168.38.

During the past 12 months, Eisai Co's average EPS without NRIGrowth Rate was 79.80% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -51.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -30.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was -7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Eisai Co's highest 3-Year average EPS without NRI Growth Rate was 64.40% per year. The lowest was -51.50% per year. And the median was 1.60% per year.

Eisai Co EPS (Diluted) Historical Data

The historical data trend for Eisai Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co EPS (Diluted) Chart

Eisai Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EPS (Diluted)

Get a 7-Day Free Trial

884.48

1,699.20

585.16

167.25

193.31

Eisai Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Diluted)	Get a 7-Day Free Trial															30.14	56.92	70.92	19.73	20.81

Competitive Comparison of Eisai Co's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eisai Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Eisai Co's PE Ratio falls into.

Eisai Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Eisai Co's Diluted EPS for the fiscal year that ended in Mar. 2023 is calculated as

Diluted EPS (A: Mar. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(55432	-	0)	/	286.761
	=	193.30

Eisai Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(5969	-	0)	/	286.833
	=	20.81

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円168.38

Eisai Co (TSE:4523) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Eisai Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Eisai Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (TSE:4523) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (TSE:4523) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

ESAIY:USA ESALF:USA EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

Eisai Co (TSE:4523) Headlines

No Headlines